These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21619383)

  • 21. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
    G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.
    Yin Y; Dalal D; Liu Z; Wu J; Liu D; Lan X; Dai Y; Su L; Ling Z; She Q; Luo K; Woo K; Dong J
    Eur Heart J; 2006 Aug; 27(15):1841-6. PubMed ID: 16825288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.
    Luo WL; Crumley T; Ebel D; Atiee GJ; Royalty J; Johnson-Levonas AO; Wagner J; Lai E
    J Clin Pharmacol; 2010 Nov; 50(11):1273-9. PubMed ID: 20107202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone-induced long QT and polymorphic ventricular tachycardia.
    Nkomo VT; Shen WK
    Am J Emerg Med; 2001 May; 19(3):246-8. PubMed ID: 11326361
    [No Abstract]   [Full Text] [Related]  

  • 28. The quest for an anti-arrhythmic drug against atrial fibrillation that combines efficacy with safety.
    Vos MA
    Europace; 2010 Jul; 12(7):925-6. PubMed ID: 20488855
    [No Abstract]   [Full Text] [Related]  

  • 29. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation.
    Pratt CM; Roy D; Torp-Pedersen C; Wyse DG; Toft E; Juul-Moller S; Retyk E; Drenning DH;
    Am J Cardiol; 2010 Nov; 106(9):1277-83. PubMed ID: 21029824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).
    Stabile G; Bertaglia E; Senatore G; De Simone A; Zoppo F; Donnici G; Turco P; Pascotto P; Fazzari M; Vitale DF
    Eur Heart J; 2006 Jan; 27(2):216-21. PubMed ID: 16214831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pirmenol hydrochloride-induced QT prolongation and T wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
    Abe H; Numata T; Hanada H; Kohshi K; Nakashima Y
    J UOEH; 1998 Dec; 20(4):339-43. PubMed ID: 9883483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Silico Predictions and In Vivo Results of Drug-Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate.
    Johansson S; Löfberg B; Aunes M; Lunde H; Frison L; Edvardsson N; Cullberg M
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):364-73. PubMed ID: 27627192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting QRS and PR interval prolongations in humans using nonclinical data.
    Bergenholm L; Parkinson J; Mettetal J; Evans ND; Chappell MJ; Collins T
    Br J Pharmacol; 2017 Oct; 174(19):3268-3283. PubMed ID: 28675424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic principle of SK channel inhibition in atrial fibrillation.
    Skibsbye L
    Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036893
    [No Abstract]   [Full Text] [Related]  

  • 35. Flecainide overdose presenting with long QT and acute Takotsubo cardiomyopathy.
    Bodziock G; Armstrong C; Montgomery J
    J Electrocardiol; 2019; 52():7-9. PubMed ID: 30476643
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndrome.
    El Yaman M; Perry J; Makielski JC; Ackerman MJ
    Heart Rhythm; 2008 Mar; 5(3):472-4. PubMed ID: 18313609
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase 1 trial of AP30663, a K
    Yfanti C; Vestbjerg B; Van't Westende J; Edvardsson N; Monfort LM; Olesen MS; Bentzen BH; Grunnet M; Eveleens Maarse BC; Diness JG; Kemme MJB; Sørensen U; Moerland M; van Esdonk MJ; Klaassen ES; Gal P; Holst AG
    Br J Clin Pharmacol; 2024 Apr; 90(4):1027-1035. PubMed ID: 37990600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamate skin contact-induced atrial fibrillation: toxicity or hypersensitivity?
    Mazaraki I; Gkouias K; Almpanis G; Kounis NG; Mazarakis A
    Int J Cardiol; 2013 Sep; 168(1):e11-2. PubMed ID: 23706324
    [No Abstract]   [Full Text] [Related]  

  • 39. On the QT.
    RuDusky BM
    Am J Cardiol; 2019 Sep; 124(6):992-993. PubMed ID: 31371061
    [No Abstract]   [Full Text] [Related]  

  • 40. QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trial.
    Egstrup K; Bergfeldt L; Duris T; Gullestad L; Kochmanski M; Kuśnierz B; Nielsen T; Sawicki S; Aunes-Jansson M; Edvardsson N; Frison L; Johansson S; Berggren A
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):199-208. PubMed ID: 21619383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.